Citadel Advisors
VASC

Citadel Advisors’s Vascular Solutions Inc VASC Stock Holding History

Citadel Advisors’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,300
Closed -$1.25M – 8513
2016
Q4 		$1.25M Buy
+22,300
New +$1.14M ﹤0.01% 3558
2016
Q1 		– Sell
-1,500
Closed -$52K – 8874
2015
Q4 		$52K Sell
1,500
-1,100
-42% -$37.3K ﹤0.01% 7288
2015
Q3 		$84K Sell
2,600
-900
-26% -$32.2K ﹤0.01% 7144
2015
Q2 		$122K Buy
3,500
+2,100
+150% +$68.5K ﹤0.01% 6892
2015
Q1 		$42K Sell
1,400
-800
-36% -$23K ﹤0.01% 7497
2014
Q4 		$60K Buy
2,200
+1,900
+633% +$51.6K ﹤0.01% 7068
2014
Q3 		$7K Sell
300
-400
-57% -$9.49K ﹤0.01% 7856
2014
Q2 		$16K Sell
700
-500
-42% -$10.9K ﹤0.01% 7430
2014
Q1 		$31K Sell
1,200
-1,300
-52% -$32.4K ﹤0.01% 7078
2013
Q4 		$58K Buy
+2,500
New +$49K ﹤0.01% 5965

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Citadel Advisors's VASC Position: Q1 2017 in Review

Citadel Advisors sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 14,436 shares — an estimated $810K sold.

Citadel Advisors first reported a position in VASC in Q4 2013 and held it in 12 quarters. The position peaked at $1.24M in Q2 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Citadel Advisors reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 14,436 Vascular Solutions Inc shares in Q1 2017, an estimated $810K.
  • Citadel Advisors first reported a position in Vascular Solutions Inc in Q4 2013 and held it in 12 quarters.
  • Citadel Advisors's Vascular Solutions Inc position peaked at $1.24M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.